PTK2 and non-small cell lung carcinoma: A recent study demonstrated that the antimigratory and anti-invasive effects of deguelin on non-small cell lung cancer are mediated by suppression of the activity of cathepsin Z and its downstream FAK/Src/paxillin pathway along with reduced phosphorylation of FAK, paxillin, and Src [76].